Syndax Pharmaceuticals, Inc.
SNDX
$18.79
-$0.33-1.73%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 27.83% | -5.56% | -17.19% | -29.94% | -64.48% |
| Total Depreciation and Amortization | 50.00% | -- | -- | -100.00% | -33.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.14% | 65.63% | 31.57% | 87.15% | 87.20% |
| Change in Net Operating Assets | -285.09% | -165.54% | -5.81% | 4.52% | 693.90% |
| Cash from Operations | -13.18% | -22.54% | -13.90% | -38.79% | -39.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -16.45% | -32.17% | 194.71% | -1,551.15% | 116.70% |
| Cash from Investing | -16.60% | -32.17% | 194.71% | -1,551.15% | 116.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 102.65% | -18.49% | -57.10% | -98.54% | 67.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 102.65% | -18.49% | -57.10% | 34.41% | 67.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.42% | -391.99% | 99.95% | -89.51% | 1,113.69% |